January 28, 2020

Shield Therapeutics Plc Good demand for Feraccru in Europe

Shield Therapeutics (LON:STX) is a commercial-stage company delivering specialty products that address patients’ unmet medical needs, with an initial focus on treating iron deficiency (ID) with ferric maltol. Recent news..

Analyst Q&A with Zeus Capital: JTC Group (LON:JTC)

JTC Group (LON:JTC) is the topic of conversation when Zeus Capital’s Research Director Robin Savage caught up with DirectorsTalk for an exclusive interview. Q1: This morning JTC Group released its..

Maritime industry now a major target for computer cyber attacks

Major advances in the rapidly changing maritime industry have made this area a top target for an increasing number of sophisticated cyber criminals.  Their computer attacks are threatening vessels and ports..

Avacta Group Q&A “Strong performance to continue” (LON:AVCT)

Avacta Group (LON:AVCT) Chief Executive Officer Alastair Smith caught up with DirectorsTalk for an exclusive interview to discuss discuss their latest trading update, the increase in revenues, better cash position..

Cambria Automobiles Analyst Q&A with Zeus Capital (LON:CAMB)

Cambria Automobiles (LON:CAMB) is the topic of conversation when Zeus Capital’s Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview. Q1: Cambria Automobiles, they’ve announced the..

Jubilee Metals Group have an exceptional period

Jubilee Metals Group (LON:JLP), the AIM and Altx traded metals processing company, has today announced its unaudited operational results for the six month period ended 31 December 2019. Highlights ·    74%..

Norman Broadbent key milestone in returning to profitability (Interview)

Norman Broadbent (LON: NBB) CEO Mike Brennan talks to DirectorsTalk about its latest trading update. Mike talks us through the key highlights, his confidence for the future, moving to larger..

McCarthy & Stone plc Results in line with expectations

McCarthy & Stone (LON: MCS), the UK’s leading developer and manager of retirement communities, announces its financial results for the 14 month period ended 31 October 2019. All comparatives are..

Greencore Group Steady progress in Q1; FY20 outlook reaffirmed

Greencore Group plc (LON: GNC), a leading manufacturer of convenience foods in the UK, today issued a trading update covering the 13 weeks to 27 December 2019. Q1 Trading1  ..

PZ Cussons Plc Progress against new strategy in challenging market conditions

PZ Cussons Plc (LON: PZC), a leading consumer products group, announced today its interim results for the six months ended 30 November 2019. Adjusted1 results (before exceptional items) Half year to..

Safestyle UK “FY19 shows material progress with market share and revenue returning strongly”

Confidence improving with marketing spend increasing back to commercial levels Safestyle UK (LON:SFE) is steadily getting back to where it was pre 2017. The management team has only been in..

J Sainsbury commits to hitting net zero by 2040

J Sainsbury (LON:SBRY) today committed to investing £1 billion over twenty years towards becoming a Net Zero business across its own operations by 2040, aligned to the highest ambitions of..

UDG Healthcare plc New Appointment and Directorate Changes

UDG Healthcare plc (LON: UDG), a leading international healthcare services provider, has today announced the appointment of Ms Liz Shanahan as a non-executive director of the Company with effect from..

Just Eat partners nationwide with McDonald’s

Just Eat (LON:JE), a leading global hybrid marketplace for online food delivery, today provided a post-close trading update for the year ending 31 December 2019, and announced that it has..

Oncimmune Holdings EarlyCDT Lung Test More Cost Effective than CT

Oncimmune Holdings plc (LON: ONC), a leading global immunodiagnostics group, is pleased to note that a recent study led by Leeds University Academic Unit of Health Economics, supported by NIHR..

SEGRO announces a number of senior leadership changes

SEGRO (LON:SGRO) today announced a number of senior leadership changes, with Phil Redding, Chief Investment officer, stepping down from the Board at the end of January and leaving the business..

Avacta Group Successful initial proof-of-concept for new class of anti-cancer therapy

Avacta Group plc (LON: AVCT), the developer of Affimer® biotherapeutics and reagents, has announced that it has demonstrated initial proof-of-concept for its proprietary new class of drug conjugate, “TMACTM”, in..

Pressure Technologies plc adds new Non-Executive Director to the board

Pressure Technologies (LON: PRES), the specialist engineering group, has announced that Tim Cooper today joins the Board of the Company as a Non-Executive Director. Tim has significant experience at senior..

Search

Funds

January 28, 2020

Search

Funds

January 28, 2020

FTSE 100

Funds